oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data is a research paper published in Briefings in Bioinformatics (2021). On theSindex it has a DataRank of 10.2. It has been cited 1,768 times, with 200 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
1.1
From this paper's citation signal
Citation Network Contribution
9.1
From 200 citing papers with measurable signal
National Institute of Health
Grant: R01CA204856
National Cancer Institute
Grant: R01CA229618
National Institutes of Health
Grant: 5R01CA229618-05
Genetic mechanisms underlying sexual dimorphism in cancer and response to therapy
National Institutes of Health
Grant: 5R01CA204856-05
Drug repurposing in breast cancer
FWCI
235.51
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Integrative analysis of TP53 mutations in lung adenocarcinoma for immunotherapies and prognosis
Additional file 1 of Integrative analysis of TP53 mutations in lung adenocarcinoma for immunotherapies and prognosis
Additional file 3 of Integrative analysis of TP53 mutations in lung adenocarcinoma for immunotherapies and prognosis
Additional file 3 of Integrative analysis of TP53 mutations in lung adenocarcinoma for immunotherapies and prognosis
Additional file 4 of Integrative analysis of TP53 mutations in lung adenocarcinoma for immunotherapies and prognosis
Additional file 4 of Integrative analysis of TP53 mutations in lung adenocarcinoma for immunotherapies and prognosis
Additional file 1 of Glycometabolism and lipid metabolism related genes predict the prognosis of endometrial carcinoma and their effects on tumor cells
Additional file 1 of Glycometabolism and lipid metabolism related genes predict the prognosis of endometrial carcinoma and their effects on tumor cells
Additional file 2 of Integrated analysis of tumor-associated macrophages and M2 macrophages in CRC: unraveling molecular heterogeneity and developing a novel risk signature
Additional file 2 of Integrated analysis of tumor-associated macrophages and M2 macrophages in CRC: unraveling molecular heterogeneity and developing a novel risk signature
Additional file 1 of The potential crosstalk between tumor and plasma cells and its association with clinical outcome and immunotherapy response in bladder cancer
Additional file 1 of The potential crosstalk between tumor and plasma cells and its association with clinical outcome and immunotherapy response in bladder cancer
Additional file 1 of Exploring the relationship between metabolism and immune microenvironment in osteosarcoma based on metabolic pathways
Additional file 1 of Exploring the relationship between metabolism and immune microenvironment in osteosarcoma based on metabolic pathways
Additional file 3 of Exploring the relationship between metabolism and immune microenvironment in osteosarcoma based on metabolic pathways
Additional file 3 of Exploring the relationship between metabolism and immune microenvironment in osteosarcoma based on metabolic pathways
Additional file 1 of Metabolic reprogramming based on RNA sequencing of gemcitabine-resistant cells reveals the FASN gene as a therapeutic for bladder cancer
Additional file 1 of Metabolic reprogramming based on RNA sequencing of gemcitabine-resistant cells reveals the FASN gene as a therapeutic for bladder cancer
Additional file 1 of Construction of a gene model related to the prognosis of patients with gastric cancer receiving immunotherapy and exploration of COX7A1 gene function
Additional file 1 of Construction of a gene model related to the prognosis of patients with gastric cancer receiving immunotherapy and exploration of COX7A1 gene function